• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ReGeneRx Biopharmaceuticals Inc

+ Add to Watchlist

RGRX:US

0.1400 USD 0.0090 6.04%

As of 20:10:00 ET on 01/22/2015.

Snapshot for ReGeneRx Biopharmaceuticals Inc (RGRX)

Open: 0.1400 Day's Range: 0.1400 - 0.1400 Volume: 5,334
Previous Close: 0.1490 52wk Range: 0.1005 - 0.2850 1-Yr Rtn: -15.15%

Stock Chart for RGRX

No chart data available.
  • RGRX:US 0.1400
  • 1D
  • 1M
  • 1Y
0.1490
Interactive RGRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RGRX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0214
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 14.18
Shares Outstanding (M) 101.32
30 Day Average Volume 27,424
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RGRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RGRX

RegeneRx Biopharmaceuticals, Inc. is focusing on the commercialization of Thymosin beta 4, a 43 amino acid peptide. The Company is concentrating its efforts on the use of Thymosin beta 4 for the treatment of injured tissue and non-healing wounds to enable more rapid repair and/or tissue regeneration.

Allan L GoldsteinChairman/Chief Scientific AdvisorJ J FinkelsteinPresident/CEO
Alan KleinInterim Chief Business Officer
More Company Profile & Key Executives for RGRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil